We are live on
!
Find out more
DCOY
Decoy Therapeutics
DCOY
DCOY
27 hedge funds and large institutions have $10.2M invested in Decoy Therapeutics in 2021 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 4 increasing their positions, 6 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
100% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 4
17% more funds holding
Funds holding: 23 → 27 (+4)
0% less ownership
Funds ownership: 0% → 0% (-0%)
33% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 6
55% less capital invested
Capital invested by funds: $22.8M → $10.2M (-$12.6M)
Holders
27
Holders Change
+4
Holders Change %
+17.39%
% of All Funds
0.47%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
4
Reduced
6
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Morgan Stanley
New York
|
+$623K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$222K |
| 3 |
BlackRock
New York
|
+$178K |
| 4 |
State Street
Boston,
Massachusetts
|
+$178K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$178K |
